Cordova Ashley, CEO of NovoCure Ltd ($NVCR), made one open market purchase of shares in the last year, totaling nearly $1 million. The latest buy occurred on September 5, 2025. This ranks 563rd among 4,983 insiders in our database, trailing the average purchase of $1.5 million over 3.3 transactions. No open market sales by Cordova Ashley in the past year.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | NovoCure Ltd | $NVCR | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 17638 | $13.30 | 422,570.0000 | 111,981,981 | 4.01% | 0.02% |
| Feb. 27, 2026 | NovoCure Ltd | $NVCR | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 11541 | $13.75 | 426,028.0000 | 111,981,981 | 2.64% | 0.01% |
| Feb. 28, 2026 | NovoCure Ltd | $NVCR | Cordova Ashley | Former Chief Executive Officer | A | Ordinary Shares | 23818 | $0.00 | 449,846.0000 | 111,981,981 | 5.59% | 0.02% |
| March 2, 2026 | NovoCure Ltd | $NVCR | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 7228 | $13.67 | 440,208.0000 | 111,981,981 | 1.62% | 0.01% |
| March 2, 2026 | NovoCure Ltd | $NVCR | Cordova Ashley | Former Chief Executive Officer | F | Ordinary Shares | 2410 | $13.67 | 447,436.0000 | 111,981,981 | 0.54% | 0.00% |
| Sept. 5, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | P | Ordinary Shares | 81550 | $12.22 | 437,569.0000 | 109,915,429 | 22.91% | 0.07% |
| June 30, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | A | Ordinary Shares | 833 | $15.13 | 356,019.0000 | 109,915,429 | 0.23% | 0.00% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | A | Stock Options (Right to buy) | 224123 | $18.19 | 224,123.0000 | 109,915,429 | 9999.99% | 0.20% |
| March 4, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | A | Ordinary Shares | 151181 | $18.19 | 355,186.0000 | 109,915,429 | 74.11% | 0.14% |
| March 3, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 2053 | $18.54 | 204,005.0000 | 109,915,429 | 1.00% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 2341 | $18.28 | 206,058.0000 | 109,915,429 | 1.12% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 9345 | $19.92 | 210,207.0000 | 109,915,429 | 4.26% | 0.01% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 1808 | $20.55 | 208,399.0000 | 109,915,429 | 0.86% | 0.00% |
| Feb. 28, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 2341 | $18.28 | 206,058.0000 | 109,915,429 | 1.12% | 0.00% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 9345 | $19.92 | 210,207.0000 | 109,915,429 | 4.26% | 0.01% |
| Feb. 27, 2025 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | S | Ordinary Shares | 1808 | $20.55 | 208,399.0000 | 109,915,429 | 0.86% | 0.00% |
| Dec. 31, 2024 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Executive Officer | A | Ordinary Shares | 373 | $14.75 | 219,552.0000 | 0 | 0.17% | 0.00% |
| June 28, 2024 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 1286 | $12.24 | 220,465.0000 | 0 | 0.59% | 0.00% |
| Aug. 2, 2024 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 688 | $20.14 | 219,179.0000 | 0 | 0.31% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 102249 | $16.30 | 219,867.0000 | 0 | 86.93% | 0.00% |
| Feb. 27, 2024 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Stock Options (Right to buy) | 156348 | $16.30 | 156,348.0000 | 0 | 9999.99% | 0.00% |
| Oct. 31, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 7561 | $0.00 | 175.0000 | 0 | 97.74% | 0.00% |
| Oct. 31, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 2480 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 31, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 7752 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 2, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Stock Option (Right to Buy) | 175 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 31, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 7561 | $11.46 | 107,211.0000 | 0 | 7.59% | 0.00% |
| Oct. 31, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 2480 | $11.44 | 109,691.0000 | 0 | 2.31% | 0.00% |
| Oct. 31, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 7752 | $7.15 | 117,443.0000 | 0 | 7.07% | 0.00% |
| Nov. 2, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | M | Ordinary Shares | 175 | $11.46 | 117,618.0000 | 0 | 0.15% | 0.00% |
| Sept. 1, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 883 | $21.82 | 99,650.0000 | 0 | 0.88% | 0.00% |
| Aug. 2, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 1144 | $30.25 | 100,533.0000 | 0 | 1.13% | 0.00% |
| June 30, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 367 | $35.28 | 101,677.0000 | 0 | 0.36% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 775 | $76.16 | 101,310.0000 | 0 | 0.76% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 4730 | $76.16 | 102,085.0000 | 0 | 4.43% | 0.00% |
| March 2, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 1055 | $75.28 | 95,007.0000 | 0 | 1.10% | 0.00% |
| March 3, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 11808 | $0.00 | 106,815.0000 | 0 | 12.43% | 0.00% |
| March 1, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | S | Ordinary Shares | 2198 | $76.36 | 96,062.0000 | 0 | 2.24% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Options to Buy Ordinary Shares | 39614 | $76.97 | 39,614.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 23818 | $0.00 | 98,260.0000 | 0 | 32.00% | 0.00% |
| Jan. 6, 2023 | NovoCure Ltd | $NVCR | Cordova Ashley | Chief Financial Officer | A | Ordinary Shares | 66 | $62.31 | 74,442.0000 | 0 | 0.09% | 0.00% |